105 related articles for article (PubMed ID: 8142169)
1. Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H
Eur J Cancer; 1994; 30A(1):74-8. PubMed ID: 8142169
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H
Jpn J Cancer Res; 1991 Sep; 82(9):987-92. PubMed ID: 1682293
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by verapamil of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M
Br J Cancer; 1993 Jul; 68(1):37-40. PubMed ID: 8100445
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
Carcinogenesis; 1993 Dec; 14(12):2601-4. PubMed ID: 7903604
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by isoproterenol of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M
Int J Cancer; 1993 Feb; 53(4):703-6. PubMed ID: 8382197
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene protein in Sprague-Dawley rats.
Baba M; Iishi H; Yamamoto R; Tatsuta M
Int J Cancer; 1991 Sep; 49(3):467-70. PubMed ID: 1917145
[TBL] [Abstract][Full Text] [Related]
7. Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Narahara H; Yano H; Sakai N
Cancer Lett; 2000 Apr; 152(1):31-6. PubMed ID: 10754203
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention by amiloride against experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Yano H; Sakai N; Uehara H; Nakaizumi A
Cancer Lett; 1997 Oct; 119(1):109-13. PubMed ID: 18372529
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by the calmodulin antagonist trifluoperazine of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Yano H; Uehara H; Nakaizumi A; Iseki K
Cancer Lett; 1996 Oct; 107(2):179-85. PubMed ID: 8947510
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by neurotensin of hepatocarcinogenesis by N-nitrosomorpholine in Sprague-Dawley rats.
Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
Cancer Lett; 1996 Dec; 110(1-2):57-61. PubMed ID: 9018081
[TBL] [Abstract][Full Text] [Related]
11. Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M; Iseki K; Yano H; Uehara H; Yamamoto R; Nakaizumi A
Br J Cancer; 1998 Feb; 77(4):581-7. PubMed ID: 9484815
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by ethyl alcohol of experimental hepatocarcinogenesis induced by N-nitrosomorpholine.
Tatsuta M; Iishi H; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
Int J Cancer; 1997 Jun; 71(6):1045-8. PubMed ID: 9185709
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association.
Kaji I; Tatsuta M; Iishi H; Baba M; Inoue A; Kasugai H
Int J Cancer; 2001 Aug; 93(3):441-4. PubMed ID: 11433412
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by cysteamine of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Tatsuta M; Iishi H; Baba M
Int J Cancer; 1989 Sep; 44(3):529-33. PubMed ID: 2570757
[TBL] [Abstract][Full Text] [Related]
15. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.
Kim DJ; Lee KK; Han BS; Ahn B; Bae JH; Jang JJ
Jpn J Cancer Res; 1994 Jun; 85(6):578-83. PubMed ID: 8063610
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of herbal compound 861 on chemical hepatocarcinogenesis in rats.
Cui R; Wang B; Zhang F; Chen G; Yin S
Chin Med J (Engl); 2003 Mar; 116(3):378-82. PubMed ID: 12781041
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of hepatocarcinogenesis in rats by dietary fructose.
Enzmann H; Ohlhauser D; Dettler T; Bannasch P
Carcinogenesis; 1989 Jul; 10(7):1247-52. PubMed ID: 2567639
[TBL] [Abstract][Full Text] [Related]
18. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
[TBL] [Abstract][Full Text] [Related]
19. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
20. Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note.
Löw-Baselli A; Huber WW; Käfer M; Bukowska K; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2000 Oct; 21(10):1869-77. PubMed ID: 11023545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
